Literature DB >> 18346184

Efficacy of recombinant adenovirus-mediated double suicide gene therapy in human keloid fibroblasts.

B Xu1, Z Z Liu, G Y Zhu, J F Yang, J P Zhao, J C Wang, J L Cai.   

Abstract

BACKGROUND: The recombinant adenovirus-mediated double suicide gene CDglyTK has been widely used for gene therapy of cancer. The biological behaviour of keloids is similar to that of cancer, in that they may extend beyond the site of injury, and do not subside. There are no effective strategies available for keloid therapy. Gene therapy is gaining greater importance in the field of plastic surgery, and the CDglyTK double suicide gene/prodrug system has been receiving greater attention. AIM: To show the lethal and bystander effects of a double suicide gene in keloid fibroblasts. Bcl-2 and BAX play an important role in the apoptosis induced by the double suicide gene.
METHODS: Recombinant adenovirus expression CDglyTK suicide genes were constructed using the modified AdEasy system. The lethal and bystander effects were measured after 48 h using the MTT assay. The morphological changes in fibroblasts were detected by haematoxylin and eosin staining, and apoptosis was detected by the terminal dUTP nick-end labelling assay. Bcl-2 and BAX were detected by immunohistochemistry and quantitative real-time PCR.
RESULTS: CDglyTK could be constructed easily and relatively quickly. The lethal and bystander effects of CDglyTK were marked in keloid fibroblasts. Apoptosis was one of the main processes leading to fibroblast death in keloids, and Bcl-2 and BAX played an important role in the process of apoptosis.
CONCLUSION: Together, the results support the notion that recombinant adenovirus-mediated CDglyTK double suicide gene therapy is effective in destroying keloid fibroblasts and provide a sound scientific rationale for keloid trials in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18346184     DOI: 10.1111/j.1365-2230.2007.02615.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  3 in total

1.  Keloid explant culture: a model for keloid fibroblasts isolation and cultivation based on the biological differences of its specific regions.

Authors:  Vanina Monique Tucci-Viegas; Bernardo Hochman; Jerônimo P França; Lydia M Ferreira
Journal:  Int Wound J       Date:  2010-10       Impact factor: 3.315

Review 2.  Managing keloid scars: From radiation therapy to actual and potential drug deliveries.

Authors:  Chenyu Huang; Longwei Liu; Zhifeng You; Yanan Du; Rei Ogawa
Journal:  Int Wound J       Date:  2019-03-12       Impact factor: 3.315

Review 3.  Understanding Keloid Pathobiology From a Quasi-Neoplastic Perspective: Less of a Scar and More of a Chronic Inflammatory Disease With Cancer-Like Tendencies.

Authors:  Silvian Tan; Nonhlanhla Khumalo; Ardeshir Bayat
Journal:  Front Immunol       Date:  2019-08-07       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.